These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 24003254)

  • 21. Angiomotin promotes renal epithelial and carcinoma cell proliferation by retaining the nuclear YAP.
    Lv M; Li S; Luo C; Zhang X; Shen Y; Sui YX; Wang F; Wang X; Yang J; Liu P; Yang J
    Oncotarget; 2016 Mar; 7(11):12393-403. PubMed ID: 26848622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition.
    Kim M; Kim M; Park SJ; Lee C; Lim DS
    EMBO Rep; 2016 Jan; 17(1):64-78. PubMed ID: 26598551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor.
    Paramasivam M; Sarkeshik A; Yates JR; Fernandes MJ; McCollum D
    Mol Biol Cell; 2011 Oct; 22(19):3725-33. PubMed ID: 21832154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis.
    Dai X; She P; Chi F; Feng Y; Liu H; Jin D; Zhao Y; Guo X; Jiang D; Guan KL; Zhong TP; Zhao B
    J Biol Chem; 2013 Nov; 288(47):34041-34051. PubMed ID: 24106267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling.
    Archibald A; Al-Masri M; Liew-Spilger A; McCaffrey L
    Mol Biol Cell; 2015 Oct; 26(20):3578-95. PubMed ID: 26269582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induced expression of AMOT reverses adriamycin resistance in breast cancer cells.
    Zhang H; Wang Y; Gao Y; Du M; Pan E; Sun M; Zhang X
    Cell Biol Int; 2024 Sep; 48(9):1301-1312. PubMed ID: 39021301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins.
    Wang W; Li N; Li X; Tran MK; Han X; Chen J
    Cell Rep; 2015 Oct; 13(3):524-532. PubMed ID: 26456820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
    Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway.
    Zhang Y; Yuan J; Zhang X; Yan F; Huang M; Wang T; Zheng X; Zhang M
    Oncol Rep; 2016 Dec; 36(6):3619-3626. PubMed ID: 27779692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiomotin Regulates YAP Localization during Neural Differentiation of Human Pluripotent Stem Cells.
    Zaltsman Y; Masuko S; Bensen JJ; Kiessling LL
    Stem Cell Reports; 2019 May; 12(5):869-877. PubMed ID: 31006631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zyxin promotes colon cancer tumorigenesis in a mitotic phosphorylation-dependent manner and through CDK8-mediated YAP activation.
    Zhou J; Zeng Y; Cui L; Chen X; Stauffer S; Wang Z; Yu F; Lele SM; Talmon GA; Black AR; Chen Y; Dong J
    Proc Natl Acad Sci U S A; 2018 Jul; 115(29):E6760-E6769. PubMed ID: 29967145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endosomal regulation of contact inhibition through the AMOT:YAP pathway.
    Cox CM; Mandell EK; Stewart L; Lu R; Johnson DL; McCarter SD; Tavares A; Runyan R; Ghosh S; Wilson JM
    Mol Biol Cell; 2015 Jul; 26(14):2673-84. PubMed ID: 25995376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 12-O-Tetradecanoylphorbol-13-acetate (TPA) is anti-tumorigenic in liver cancer cells via inhibiting YAP through AMOT.
    Zhu G; Chen Y; Zhang X; Wu Q; Zhao Y; Chen Y; Sun F; Qiao Y; Wang J
    Sci Rep; 2017 Mar; 7():44940. PubMed ID: 28322318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
    Hao Y; Chun A; Cheung K; Rashidi B; Yang X
    J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
    Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
    Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polarity-dependent distribution of angiomotin localizes Hippo signaling in preimplantation embryos.
    Hirate Y; Hirahara S; Inoue K; Suzuki A; Alarcon VB; Akimoto K; Hirai T; Hara T; Adachi M; Chida K; Ohno S; Marikawa Y; Nakao K; Shimono A; Sasaki H
    Curr Biol; 2013 Jul; 23(13):1181-94. PubMed ID: 23791731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis.
    Fang L; Teng H; Wang Y; Liao G; Weng L; Li Y; Wang X; Jin J; Jiao C; Chen L; Peng X; Chen J; Yang Y; Fang H; Han D; Li C; Jin X; Zhang S; Liu Z; Liu M; Wei Q; Liao L; Ge X; Zhao B; Zhou D; Qin HL; Zhou J; Wang P
    Cancer Cell; 2018 Jul; 34(1):103-118.e9. PubMed ID: 30008322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conditional knockout of TFPI-1 in VSMCs of mice accelerates atherosclerosis by enhancing AMOT/YAP pathway.
    Xiao J; Jin K; Wang J; Ma J; Zhang J; Jiang N; Wang H; Luo X; Fei J; Wang Z; Yang X; Ma D
    Int J Cardiol; 2017 Feb; 228():605-614. PubMed ID: 27875740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein.
    Zhao B; Kim J; Ye X; Lai ZC; Guan KL
    Cancer Res; 2009 Feb; 69(3):1089-98. PubMed ID: 19141641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis.
    Lee KP; Lee JH; Kim TS; Kim TH; Park HD; Byun JS; Kim MC; Jeong WI; Calvisi DF; Kim JM; Lim DS
    Proc Natl Acad Sci U S A; 2010 May; 107(18):8248-53. PubMed ID: 20404163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.